CIRM Funded Clinical Trials

Phase I Trial of Locoregionally Delivered Autologous B7-H3 CAR T Cells (B7-H3CART) in Adults with Recurrent Glioblastoma Multiforme

Disease Area:

Investigator:

Dr. Reena Parada Thomas

Institution:

Stanford University

CIRM Grant:

CLIN2-15094 (Active)

Award Value:

$11,999,991.00

Trial Sponsor:

Stanford University

Trial Stage:

Phase 1

Trial Status:

Launching

Targeted Enrollment:

N/A